ArticlePDF Available

Acute Superficial Vein Thrombosis of the Upper Extremity: A Case Report

Authors:

Abstract and Figures

Superficial vein thrombosis has traditionally been considered a disease of the lower extremity. Less frequently it can affect the breast, chest wall, penis, or upper extremity. Cases involving upper extremities are usually associated with intravascular access, and the vast majority remain self-limiting. This case report presents a 63-year-old patient who had acute extensive thrombosis of cephalic and basilic venous systems following resection of a desmoid tumor from the flank. This was likely related to intraoperative positioning and resulted in severe symptoms mimicking deep vein thrombosis and carpal tunnel syndrome. Additionally, diagnostic tools available to the hand surgeon that allow prompt diagnosis, management, and prevention are discussed.
Content may be subject to copyright.
www.PRSGlobalOpen.com 1
Disclosure: None of the authors has a nancial interest in
any of the products, devices, or drugs mentioned in this article.
From the Department of Plastic Surgery, Cleveland Clinic,
Cleveland, Ohio.
Received for publication August 26, 2020; accepted October 21,
2020.
Copyright © 2020 The Authors. Published by Wolters Kluwer Health,
Inc. on behalf of The American Society of Plastic Surgeons. This
is an open-access article distributed under the terms of the Creative
Commons Attribution-Non Commercial-No Derivatives License 4.0
(CCBY-NC-ND), where it is permissible to download and share the
work provided it is properly cited. The work cannot be changed in
any way or used commercially without permission from the journal.
DOI: 10.1097/GOX.0000000000003322
Hand/Peripheral Nerve
Supercial thrombophlebitis is an inammation of
the supercial veins associated with supercial vein
thrombosis (SVT). Traditionally, it has been consid-
ered a disease of the lower extremity.1 Less frequently, it
can affect the breast, chest wall, penis, or upper extrem-
ity.2–6 Cases involving upper extremities are primarily
associated with intravascular access and usually remain
self-limiting. This report presents a patient who developed
acute thrombosis of cephalic and basilic venous systems,
likely related to intraoperative positioning, that mani-
fested with severe symptoms.
CASE REPORT
This case involves a 63-year-old right-hand-dominant
ofce worker who presented for resection of a right
ank desmoid tumor. Her BMI was 21.7 kg/m2. Relevant
past medical history included hypertension treated with
oral lisinopril 10 mg QD, and left greater saphenous
SVT following shoulder surgery for adhesive capsulitis
8 years prior, for which she had received a 2-month-
long course of subcutaneous enoxaparin 40 mg QD. Past
medical work-up was negative for hypercoagulopathy
and malignancy. The patient denied a prior history of
hand trauma or compression neuropathy. Her Caprini
score was 7.
On the day of surgery, a peripheral intravenous line
was placed in the left dorsal hand and intravenous normal
saline infusion started 2 hours before surgery. The patient
was given 5000 IU of unfractionated heparin for deep vein
thrombosis (DVT) prophylaxis and was then taken to the
operating room, placed under general anesthesia, and posi-
tioned in the left side down lateral decubitus position with
an axillary roll. The tumor was radically resected and the
defect was closed primarily in 87 minutes. Immediately after
the procedure, the surgical team noted generalized edema,
discoloration, tenderness, and coolness of the left hand with
paresthesias in the median nerve distribution. One hour
after surgery, swelling and discoloration propagated to the
level of the mid-forearm despite extremity elevation (Fig.1).
At that time, differential diagnosis included DVT. A bed-
side ultrasound performed by the hand surgery team using
Sonosite Edge 7-MHz linear transducer (FUJIFILM Sonosite
Inc., Bothwell, Wash.) and the technique described before
revealed thrombosis of the basilic and cephalic veins extend-
ing from the level of the proximal arm to the distal forearm
(Fig.2).5 There were no arterial or deep vein abnormalities
noted. A formal duplex ultrasound was then requested and
conrmed this diagnosis. The vascular medicine service
was consulted and initiated continuous medium-level com-
pression therapy with elastic glove and sleeve, oral ibupro-
fen 400 mg QID, and subcutaneous enoxaparin 40 mg QD.
Hypercoagulability work-up was negative. On postoperative
day 1, coolness and paresthesias resolved, and the patient was
discharged from the hospital.
At 2 weeks postoperative, repeat left arm duplex
showed no propagation of the thrombus and no DVT. Due
to patient’s preference and persistent swelling and palpa-
ble cords along the involved veins, decision was made to
switch enoxaparin to therapeutic dose oral rivaroxaban
Grzegorz J. Kwiecien, MD
Demetrius M. Coombs, MD
Nicholas Sinclair, MD
Brian R. Gastman, MD
Bahar Bassiri Gharb, MD, PhD
Antonio Rampazzo, MD, PhD
Summary: Supercial vein thrombosis has traditionally been considered a disease
of the lower extremity. Less frequently it can affect the breast, chest wall, penis,
or upper extremity. Cases involving upper extremities are usually associated with
intravascular access, and the vast majority remain self-limiting. This case report
presents a 63-year-old patient who had acute extensive thrombosis of cephalic and
basilic venous systems following resection of a desmoid tumor from the ank. This
was likely related to intraoperative positioning and resulted in severe symptoms
mimicking deep vein thrombosis and carpal tunnel syndrome. Additionally, diag-
nostic tools available to the hand surgeon that allow prompt diagnosis, manage-
ment, and prevention are discussed. (Plast Reconstr Surg Glob Open 2020;8:e3322; doi:
10.1097/GOX.0000000000003322; Published online 21 December 2020.)
Acute Supercial Vein Thrombosis of the Upper
Extremity: A Case Report
CASE REPORT
PRS Global Open 2020
2
20 mg QD. At 8 weeks post-operatively, the swelling and
discoloration were minimal but the palpable, tender
cords persisted. Ultrasound showed partial resolution of
the thrombus, extending from the distal arm to the distal
forearm. At the present time, 3 months post-operatively,
patient’s symptoms have resolved and she was advised to
discontinue compression and anticoagulation.
DISCUSSION
SVT of the upper extremity is usually a self-limiting
condition.7 Herein, we present a patient with extensive
thrombosis of cephalic and basilic veins, resulting in acute
venous congestion mimicking DVT and acute carpal tun-
nel syndrome.
Diagnosis
Diagnosis of SVT is usually clinical, especially when ten-
der and inamed veins can be identied.2,8 Vascular ultra-
sound is often performed to conrm the diagnosis and to
rule out coexisting DVT or other pathologies—eg, arterial
thrombosis, pseudoaneurysm, and venous incompetence,
among others. SVT may coexist with DVT in 5%−53% of
Fig. 1. Appearance of patient’s hands 1 hour after surgery. Marked venous congestion of the left hand
and distal forearm can be appreciated on the dorsal (A) and volar (B) view.
Fig. 2. Sonographic visualization of the cephalic vein (V) at the midforearm level. A, Appearance of the
thrombosed cephalic vein (V) without compression. B, Appearance of the thrombosed cephalic vein
with compression by the ultrasound probe. Inability to collapse the vein conrms the presence of a
thrombus within the vessel lumen.
Kwiecien et al. Acute Venous Thrombosis in the Upper Extremity
3
patients.9,10 Furthermore, when it involves veins near the
junction with the axillary vein, it is considered an equivalent
of DVT.9,10 Bedside ultrasound performed by a surgeon has
been shown to be an efcient tool in diagnosis of numer-
ous conditions of the upper extremity.11,12 In this case, it
facilitated prompt diagnosis without the delay associated
with formal ultrasound performed by a technician. This
is crucial, as delay in treatment may cause propagation of
the supercial thrombus, with progression to proper DVT
and pulmonary embolism.9,10,13 Delayed treatment has also
been shown to contribute to permanent skin discoloration
and infections.8 Finally, the patient likely had subclinical
carpal tunnel syndrome, which became symptomatic with
acute wrist swelling.14 Bedside ultrasound can be used to
evaluate diameter of the median nerve. Although it was
not performed in the presented case, an increase in cross-
section area of the nerve may guide treatment.
Treatment
In most cases, SVT is a self-limiting condition and treat-
ment is mainly symptomatic with warm compresses, anti-
inammatory medications, compression, and elevation.
When symptoms are severe, the thrombus is extensive,
or it is in close proximity of the vessels emptying into the
deep venous system, an anticoagulant is usually used to
minimize the risk of progression to DVT and subsequent
pulmonary embolism. Occasionally, when a patient can-
not tolerate anticoagulation, a close follow-up with serial
ultrasound or surgical thrombectomy may be indicated.2
The patient presented was treated with all available non-
surgical modalities. Despite aggressive management, her
symptoms did not resolve until 3 months after surgery,
indicating that SVT can be a debilitating complication.
Prevention
Understanding risk factors for SVT is a key to pre-
vention.7 The patient had several risk factors, including
intravenous line, age over 60 years, prior history of SVT,
and duration of the procedure over 45 minutes. In addi-
tion, the lateral decubitus position with an axillary roll
likely caused external pressure on the proximal arm that
impaired venous outow, established intravascular stasis,
and ultimately predisposed her to thrombosis. Avoiding
intravenous lines and pressure cuffs in the extremity in
downward position, alternative choice of positioning, use
of compression devices or garments, or prophylactic pre-
and postoperative anticoagulation in high-risk patients
may minimize the risk for both DVT and SVT. Finally,
recurrent episodes of SVT, often termed migratory throm-
bophlebitis, should be investigated for possible underly-
ing malignancy—eg, Trousseau’s syndrome.
CONCLUSIONS
Upper extremity SVT can present with severe symp-
toms when cephalic and basilic veins are involved. Bedside
ultrasound performed by a surgeon is an excellent tool
that can provide immediate answers and prevent unnec-
essary delays in treatment. Despite immediate treatment,
symptoms of SVT can persist for months, substantially
affecting patients’ recovery and satisfaction.
Antonio Rampazzo, MD, PhD
Cleveland Clinic, Department of Plastic Surgery, Desk A60
9500 Euclid Avenue
Cleveland, OH 44195
E-mail: rampazza@ccf.org
REFERRENCES
1. Di Nisio M, Wichers IM, Middeldorp S. Treatment for super-
cial thrombophlebitis of the leg. Cochrane Database Syst Rev.
2013;4:CD004982.
2. Cosmi B. Management of supercial vein thrombosis. J Thromb
Haemost. 2015;13:1175–1183.
3. Bird V, Krasnokutsky S, Zhou HS, et al. Traumatic thrombophle-
bitis of the supercial dorsal vein of the penis: An occupational
hazard. Am J Emerg Med. 1997;15:67–69.
4. Loos B, Horch RE. Mondor’s disease after breast reduction sur-
gery. Plast Reconstr Surg. 2006;117:129e–132e.
5. Ploton G, Pistorius MA, Raimbeau A, et al. A STROBE cohort
study of 755 deep and supercial upper-extremity vein thrombo-
sis. Medicine (Baltimore). 2020;99:e18996.
6. Bleker SM, van Es N, Kleinjan A, et al. Current management
strategies and long-term clinical outcomes of upper extremity
venous thrombosis. J Thromb Haemost. 2016;14:973–981.
7. Chin EE, Zimmerman PT, Grant EG. Sonographic evaluation
of upper extremity deep venous thrombosis. J Ultrasound Med.
2005;24:829–38; quiz 839.
8. Nasr H, Scriven JM. Supercial thrombophlebitis (supercial
venous thrombosis). BMJ. 2015;350:h2039.
9. Chengelis DL, Bendick PJ, Glover JL, et al. Progression of super-
cial venous thrombosis to deep vein thrombosis. J Vasc Surg.
1996;24:745–749.
10. Bergqvist D, Jaroszewski H. Deep vein thrombosis in patients
with supercial thrombophlebitis of the leg. Br Med J (Clin Res
Ed). 1986;292:658–659.
11. Jacob DD, Kwiecien GJ, Cakmakoglu C, et al. Color duplex ultra-
sound for localization of vascular compromise in microsurgical
breast reconstruction. Plast Reconstr Surg. 2020;145:666e–667e.
12. Vögelin E. Ultrasonography: The third eye of hand surgeons. J
Hand Surg Eur Vol. 2020;45:219–225.
13. Cascella M, Viscardi D, Bifulco F, et al. Postoperative massive
pulmonary embolism due to supercial vein thrombosis of the
upper limb. J Clin Med Res. 2016;8:338–341.
14. Figus A, Iwuagwu FC, Elliot D. Subacute nerve compres-
sions after trauma and surgery of the hand. Plast Reconstr Surg.
2007;120:705–712.
... Regardless, recognition that a history of SVT is a significant risk factor for developing venous thromboembolism has increased [7]. SVT most frequently affects the lower extremity and infrequently affects the breast, chest wall, penis, or upper extremity [8]. This article presents a case of acute superficial thrombosis and DVT in the upper limb following recurrent anterior shoulder dislocation. ...
Article
Full-text available
The shoulder joint is a commonly dislocated joint in the human body. Shoulder dislocations are commonly associated with fractures of greater tuberosity and neurovascular injuries and are rarely associated with venous complications like deep vein thrombosis (DVT). Ten percent of all venous thrombosis is related to upper extremity venous thrombosis (UE-VT). Severe UE-VT cases are associated with endovenous catheters. Moreover, UE-VT often occurs in specific medical conditions, including hematological malignancy, solid neoplasia, and progressive infection. UE-VT can lead to serious complications such as pulmonary embolism and postthrombotic syndrome. This article presents a case of acute superficial thrombus in the cephalic vein and DVT in the subclavian vein following recurrent shoulder dislocation, which we believe is a rare presentation.
... The term superficial thrombophlebitis can be used in the case of an inflammatory reaction of the wall of the thrombosed vein [1]. This is a relatively frequent condition, but quite rare in the upper limbs outside the presence of a central venous catheter [4,5]. Its diagnosis is based on the clinical triad: pain, redness, induration. ...
Article
» Lateral decubitus positioning is a nonanatomical position used for multiple orthopaedic procedures to obtain adequate surgical exposure. » Unique ophthalmologic, musculoskeletal, neurovascular, and hemodynamic complications may arise inadvertently from positioning. » Orthopaedic surgeons should be aware of the possible complications that may manifest from placing patients in the lateral decubitus position to adequately prevent and to properly manage them.
Article
Full-text available
Objective: Cranioplasty remains an essential procedure following craniectomy but is associated with high morbidity. We investigated factors associated with outcomes following first alloplastic cranioplasty. Methods: A single-centre, retrospective cohort study of patients undergoing first alloplastic cranioplasty at a tertiary neuroscience centre (01 March 2010-01 September 2021). Patient demographics and craniectomy/cranioplasty details were extracted. Primary outcome was all-cause explantation. Secondary outcomes were explantation secondary to infection, surgical morbidity and mortality. Multivariable analysis was performed using Cox proportional hazards regression or binary logistic regression. Results: Included were 287 patients with a mean age of 42.9 years [SD = 15.4] at time of cranioplasty. The most common indication for craniectomy was traumatic brain injury (32.1%, n = 92). Cranioplasty materials included titanium plate (23.3%, n = 67), hydroxyapatite (22.3%, n = 64), acrylic (20.6%, n = 59), titanium mesh (19.2%, n = 55), hand-moulded PMMA cement (9.1%, n = 26) and PEEK (5.6%, n = 16). Median follow-up time after cranioplasty was 86.5 months (IQR 44.6-111.3). All-cause explantation was 12.2% (n = 35). Eighty-three patients (28.9%) had surgical morbidity. In multivariable analysis, the risk of all-cause explantation and explantation due to infection was reduced with the use of both hydroxyapatite (HR 0.22 [95% CI 0.07-0.71], p = .011, HR 0.22 [95% CI 0.05-0.93], p = .040) and acrylic (HR 0.20 [95% CI 0.06-0.73], p = .015, HR 0.24 [95% CI 0.06-0.97], p = .045), respectively. In addition, risk of explantation due to infection was increased when time to cranioplasty was between three and six months (HR 6.38 [95% CI 1.35-30.19], p = .020). Mean age at cranioplasty (HR 1.47 [95% CI 1.03-2.11], p = .034), titanium mesh (HR 5.36 [95% CI 1.88-15.24], p = .002), and use of a drain (HR 3.37 [95% CI 1.51-7.51], p = .003) increased risk of mortality. Conclusions: Morbidity is high following cranioplasty, with over a tenth requiring explantation. Hydroxyapatite and acrylic were associated with reduced risk of all-cause explantation and explantation due to infection. Cranioplasty insertion at three to six months was associated with increased risk of explantation due to infection.
Article
Full-text available
Upper extremity vein thrombosis (UE-VT) are more and more frequent pathologies and yet little studied. The aim is to describe the clinical and ultrasound features, UE-VT-related diseases, and the prevalence of pulmonary embolism (PE) and associated deaths. All UE-VT patients diagnosed by Doppler-ultrasound in Nantes University Hospital, from January 2015 to December 2017, were included retrospectively. UE-VT suspicion patterns, clinical features, UE-VT topography, and prevalence of PE and death were analyzed. Seven hundred and fifty-five UE-VT were analyzed, including 427 deep thrombosis (UE-DVT) and 328 superficial thrombosis (UE-SVT). In 86.2% (n = 651) UE-VT were related to endovascular devices. Among these thrombosis, one third is in connection with a PICC LINE and one quarter with a peripheral venous line. Forty nine percent (n = 370) of the patients had solid neoplasia or hematological malignancies. An inflammatory or systemic infectious context was found in 40.8% (n = 308) of the cases. The most frequently observed clinical sign at the UE-VT diagnosis was edema (28.6%). Among the UE-SVT it was the presence of an indurated cord (33.2%) and among the UE-DVT the indication of the Doppler-ultrasound was mainly a suspicion of infection on endovascular device (35.1%). In 10.6% (n = 80) of the cases the UE-VT were asymptomatic. The most frequently thrombosed veins were brachial basilic veins (16.7% of all thrombosed segments) followed by jugular (13%) and subclavian (12.3%) veins; 61.3% (n = 463) of UE-VT were in the right upper extremity; 63.3% (n = 478) UE-VT were occlusive. The occurrence of PE is 4% and the death rate is 10.2%, mainly related to the severe comorbidities of patients with UE-VT. UE-VT occurs in particular clinical contexts (hematological malignancies, solid cancers, systemic infections) and in the majority of endovascular devices (86.2%). The occurrence of PE is low.
Article
Full-text available
It is well known that deep vein thrombosis of the upper extremities is linked to high morbidity/mortality, resulting in 12-20% of all documented pulmonary embolism; however, there are few data about thromboembolism originating from a vein and/or a branch of a superficial vein of the upper extremities. Pulmonary embolism secondary to upper limb superficial vein thrombosis (not combined with upper extremities deep vein thrombosis) is a very rare clinical manifestation with few cases reported in the literature. We report a rare case of thrombophlebitis in departure from a superficial branch of the cephalic vein of the right arm, complicated by cardiac arrest secondary to a massive pulmonary embolism in a patient who underwent major surgery for ovarian cancer. We discuss on the numerous thrombotic risk factors, triggering a cascade of reactions and resulting in a potential fatal clinical manifestation.
Article
High-resolution ultrasonography is an important tool used for the diagnosis and management of inflammatory arthritis of the hand and wrist. This imaging modality has also proven its utility in the evaluation of traumatic lesions of tendons, nerves, annular pulleys, ligaments, and carpal and digital injuries and for detecting foreign bodies and causes of joint locking. One of the great advantages is the possibility of getting an internal image of the involved anatomical structure in axial, coronal, and transversal planes, as well as the option for observing dynamic changes during motion. Examiners may view the structures in the way it suits them best. The objective of this article is to summarize the author’s own experience, to point out the advantage of ultrasonography in diagnosing some selective traumatic and non-traumatic lesions, and to highlight its role in these conditions.
Article
Background: The optimal treatment of superficial thrombophlebitis (ST) of the legs remains poorly defined. While improving or relieving the local painful symptoms, treatment should aim at preventing venous thromboembolism (VTE), which might complicate the natural history of ST. This is the third update of a review first published in 2007. Objectives: To assess the efficacy and safety of topical, medical, and surgical treatments for ST of the leg in improving local symptoms and decreasing thromboembolic complications. Search methods: For this update, the Cochrane Vascular Information Specialist searched the Cochrane Vascular Specialised Register (March 2017), CENTRAL (2017, Issue 2), and trials registries (March 2017). We handsearched the reference lists of relevant papers and conference proceedings. Selection criteria: Randomised controlled trials (RCTs) evaluating topical, medical, and surgical treatments for ST of the legs that included people with a clinical diagnosis of ST of the legs or objective diagnosis of a thrombus in a superficial vein. Data collection and analysis: Two authors assessed the trials for inclusion in the review, extracted the data, and assessed the quality of the studies. Data were independently extracted from the included studies and any disagreements resolved by consensus. We assessed the quality of the evidence using the GRADE approach. Main results: We identified three additional trials (613 participants), therefore this update considered 33 studies involving 7296 people with ST of the legs. Treatment included fondaparinux; rivaroxaban; low molecular weight heparin (LMWH); unfractionated heparin (UFH); non-steroidal anti-inflammatory drugs (NSAIDs); compression stockings; and topical, intramuscular, or intravenous treatment to surgical interventions such as thrombectomy or ligation. Only a minority of trials compared treatment with placebo rather than an alternative treatment and many studies were small and of poor quality. Pooling of the data was possible for few outcomes, and none were part of a placebo-controlled trial. In one large, placebo-controlled RCT of 3002 participants, subcutaneous fondaparinux was associated with a significant reduction in symptomatic VTE (risk ratio (RR) 0.15, 95% confidence interval (CI) 0.04 to 0.50; moderate-quality evidence), ST extension (RR 0.08, 95% CI 0.03 to 0.22; moderate-quality evidence), and ST recurrence (RR 0.21, 95% CI 0.08 to 0.54; moderate-quality evidence) relative to placebo. Major bleeding was infrequent in both groups with very wide CIs around risk estimate (RR 0.99, 95% CI 0.06 to 15.86; moderate-quality evidence). In one RCT on 472 high-risk participants with ST, fondaparinux was associated with a non-significant reduction of symptomatic VTE compared to rivaroxaban 10 mg (RR 0.33, 95% CI 0.03 to 3.18; low-quality evidence). There were no major bleeding events in either group (low-quality evidence). In another placebo-controlled trial, both prophylactic and therapeutic doses of LMWH (prophylactic: RR 0.44, 95% CI 0.26 to 0.74; therapeutic: RR 0.46, 95% CI 0.27 to 0.77) and NSAIDs (RR 0.46, 95% CI 0.27 to 0.78) reduced the extension (low-quality evidence) and recurrence of ST (low-quality evidence) in comparison to placebo, with no significant effects on symptomatic VTE (low-quality evidence) or major bleeding (low-quality evidence). Overall, topical treatments improved local symptoms compared with placebo, but no data were provided on the effects on VTE and ST extension. Surgical treatment combined with elastic stockings was associated with a lower VTE rate and ST progression compared with elastic stockings alone. However, the majority of studies that compared different oral treatments, topical treatments, or surgery did not report VTE, ST progression, adverse events, or treatment adverse effects. Authors' conclusions: Prophylactic dose fondaparinux given for 45 days appears to be a valid therapeutic option for ST of the legs for most people. The evidence on topical treatment or surgery is too limited and does not inform clinical practice about the effects of these treatments in terms of VTE. Further research is needed to assess the role of rivaroxaban and other direct oral factor-X or thrombin inhibitors, LMWH, and NSAIDs; the optimal doses and duration of treatment in people at various risk of recurrence; and whether a combination therapy may be more effective than single treatment. Adequately designed and conducted studies are required to clarify the role of topical and surgical treatments.
Article
Background: There is scant information on the optimal management and clinical outcome of deep and superficial vein thrombosis of the upper extremity (UEDVT and UESVT). Objectives: To explore treatment strategies and the incidence of recurrent venous thromboembolism (VTE), mortality, postthrombotic symptoms and bleeding in patients with UEDVT and UESVT, and to assess the prognosis of cancer patients with UEDVT. Patients/methods: Follow-up of patients with UEDVT or UESVT, who were enrolled previously in a diagnostic management study. Results: We followed 102 and 55 patients with UEDVT and UESVT respectively, both for a median of 3.5 years. Anticoagulant treatment was started in 100 patients with UEDVT (98%) and in 40 (73%) with UESVT. Nine patients with UEDVT (9%) developed recurrent VTE, 26 (26%) died, 6 of 72 patients (8%) had moderate postthrombotic symptoms and 5 (5%) experienced major bleeding. One patient with UESVT had a recurrent VTE, 18 (33%) died, none had moderate postthrombotic symptoms and none had major bleeding. Of the cancer patients with UEDVT, 18% had recurrent VTE versus 7.5% in non-cancer patients (adjusted HR 2.2, 95%CI 0.6 to 8.2). The survival rate was 50% in cancer patients with UEDVT versus 60% in those without (adjusted HR 0.8, 95%CI 0.4 to 1.4). Conclusions: The risk of recurrent VTE was low in patients with UEDVT, and negligible for UESVT. Mortality was high for both diseases. Postthrombotic symptoms were infrequent and mild. Anticoagulant therapy of UEDVT carried a substantial risk of major bleeding. Cancer patients had a significant risk of recurrent VTE. This article is protected by copyright. All rights reserved.
Article
#### The bottom line Superficial thrombophlebitis (increasingly being called superficial venous thrombosis) is inflammation of the superficial veins associated with venous thrombosis. Traditionally, it has been considered a benign, self limiting disease of the lower extremity. However, it can affect most superficial venous systems in the body and importantly can be associated with deep vein thrombosis and pulmonary embolism. Treatment is aimed at symptomatic control and prevention of these serious and potentially fatal complications. Treatment options are variable and controversial. The incidence of superficial thrombophlebitis remains unclear but is thought to be higher than that of deep vein thrombosis, which is estimated at about one per 1000.1 Although age is not an independent risk factor, the incidences of other risk factors increase with age, making superficial thrombophlebitis more common in older people, and more common in women (50–70%).2 3 4 However, complications are less likely in those over 60 years old.5 Superficial thrombophlebitis is a clinical diagnosis. Patients usually present with pain and discoloration (redness in the acute phase progressing to a brown, haemosiderin based pigmentation over days to weeks) over the affected superficial veins (fig 1⇓). On palpation, the vein is tender and hard. Extensive limb swelling should raise the suspicion of deep vein thrombosis rather than superficial thrombophlebitis. Fig 1 Typical superficial thrombophlebitis within …
Article
Superficial vein thrombosis (SVT) is less well studied than deep vein thrombosis (DVT) because it has been considered a minor, self-limiting disease, easily diagnosed on clinical grounds and deserving only symptomatic relief. The most frequently involved area of the superficial vein system is the lower limbs, especially the saphenous veins, mostly in relation to varicosities. Lower limb SVT shares the same risk factors as DVT; it can propagate into the deep veins and have a complicated course with pulmonary embolism. Clinical diagnosis may not be accurate and nowadays ultrasonography is indicated for both confirmation and evaluation of SVT extension. Treatment aims are symptom relief and prevention of venous thromboembolism (VTE) in relation to the thrombotic burden. SVT of the long saphenous vein within 3 cm of the sapheno-femoral junction (SFJ) is considered equivalent to a DVT and thus deserving therapeutic anticoagulation. Less severe forms of SVT of the lower limbs not involving the SFJ have been included in randomized clinical trials of surgery, compression hosiery, non-steroidal anti-inflammatory agent, unfractionated heparin, low molecular weight heparins with inconclusive results. The largest randomized clinical trial available on 3004 patients with lower limb SVT not involving SFJ showed that fondaparinux 2.5 mg once daily for 6 weeks is more effective than placebo in reducing the risk of the composite of death from any cause and symptomatic VTE (0.9% vs.5.9%). Further studies are needed to define the optimal management strategies of SVT of the lower limbs and other sites, such as the upper limbs. This article is protected by copyright. All rights reserved. This article is protected by copyright. All rights reserved.
Article
We have evaluated the progression of isolated superficial venous thrombosis to deep vein thrombosis in patients with no initial deep venous involvement. Patients with thrombosis isolated to the superficial veins with no evidence of deep venous involvement by duplex ultrasound examination were evaluated by follow-up duplex ultrasonography to determine the incidence of disease progression into the deep veins of the lower extremities. Initial and follow-up duplex scans evaluated the femoropopliteal and deep calf veins in their entirety; follow-up studies were done at an average of 6.3 days, ranging from 2 to 10 days. From January 1992 to January 1996, 263 patients were identified with isolated superficial venous thrombosis. Thirty (11%) patients had documented progression to deep venous involvement. The most common site of deep vein involvement was progression of disease from the greater saphenous vein in the thigh into the common femoral vein (21 patients, 70%), with 18 of these extensions noted to be nonocclusive and 12 having a free-floating component. Three patients had extended above-knee saphenous vein thrombi through thigh perforators to occlude the femoral vein in the thigh, three patients had extended below-knee saphenous disease into the popliteal vein, and three patients had extended below-knee thrombi into the tibioperoneal veins with calf perforators. At the time of the follow-up examination all 30 patients were being treated without anticoagulation. Proximal saphenous vein thrombosis should be treated with anticoagulation or at least followed by serial duplex ultrasound evaluation so that definitive therapy may be initiated, if progression is noted. More distal superficial venous thrombosis should be carefully followed clinically and repeat duplex ultrasound scans performed, if progression is noted or patient symptoms worsen.